News

Analysis of leaf extract reveals novel chemistry for therapeutic ion channel activation.

Age-related declines in abstract reasoning ability predict increasing depressive symptoms in subsequent years, according to data from a longitudinal study of older adults in Scotland. The research is published in Psychological Science, a journal of the Association for Psychological Science.

Regular early head circumference assessments add valuable information when screening for long-term neurocognitive risk – according to new research by an international research collaboration, including the University of Warwick, UK and the University of Tennessee Knoxville, US.

A 15-minute scan could help diagnose brain damage in babies up to two years earlier than current methods.

Expect a shot to hurt and it probably will, even if the needle poke isn’t really so painful. Brace for a second shot and you’ll likely flinch again, even though—second time around—you should know better. That’s the takeaway of a new brain imaging study which found that expectations about pain intensity can become self-fulfilling prophecies.

Intensive behavioral therapy (IBT), which provides diet and physical activity counseling, could help adults with obesity achieve meaningful weight loss in six to 12 months. The trial showed that patients who received IBT lost an average of 6.1 percent of their initial body weight at one year.

Researchers use gait speed as a way to identify patients who might have difficulties recovering from surgery, or other health issues.

Shedding light on neural regeneration mechanism by recognizing subtle variation in the gradient profiles of guidance molecules.

The cognitive skills and personality of a future employee are examined during a job interview. However, qualifications and a nice character don’t necessarily mean that the interviewee will be a good boss or a competent colleague. To overcome this, Researchers have devised an emotional intelligence test that measures emotional competences at work.

Old age is the greatest risk factor for many diseases, including Alzheimer's disease (AD) and cancer. Geroprotectors are a recently identified class of anti-aging compounds. New research has now identified a unique subclass of these compounds, dubbed geroneuroprotectors (GNPs), which are AD drug candidates and slow the aging process in mice.